Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T98293 | Target Info | |||
Target Name | PAK-4 protein kinase (PAK4) | ||||
Synonyms |
p21-activated kinase 4; Serine/threonine-protein kinase PAK 4; PAK-4; KIAA1142
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | PAK4 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | PAK-1 protein kinase (PAK1) | Literature-reported Target | ||||
UniProt ID | PAK1_HUMAN | |||||
Gene Name | PAK1 | |||||
Synonyms |
p65-PAK; p21-activated kinase 1; Serine/threonine-protein kinase PAK 1; PAK-1; Alpha-PAK
Click to Show/Hide
|
|||||
Representative Drug(s) | PF-3758309 | Drug Info | IC50 = 13.7 nM | [1] | ||
Co-Target Name | PAK-2 protein kinase (PAK2) | Literature-reported Target | ||||
UniProt ID | PAK2_HUMAN | |||||
Gene Name | PAK2 | |||||
Synonyms |
p21-activated kinase 2; Serine/threonine-protein kinase PAK 2; S6/H4 kinase; PAK65; PAK-2; Gamma-PAK
Click to Show/Hide
|
|||||
Representative Drug(s) | PF-3758309 | Drug Info | IC50 = 190 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PAK 6 (PAK6) | Co-Target | ||||
UniProt ID | PAK6_HUMAN | |||||
Gene Name | PAK6 | |||||
Synonyms |
PAK-5; p21-activated kinase 6; PAK-6
Click to Show/Hide
|
|||||
Representative Drug(s) | PF-3758309 | Drug Info | IC50 = 17.1 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PAK 5 (PAK5) | Co-Target | ||||
UniProt ID | PAK5_HUMAN | |||||
Gene Name | PAK5 | |||||
Synonyms |
p21-activated kinase 5; PAK-5; p21-activated kinase 7; PAK-7
Click to Show/Hide
|
|||||
Representative Drug(s) | PF-3758309 | Drug Info | IC50 = 18.1 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PAK 3 (PAK3) | Co-Target | ||||
UniProt ID | PAK3_HUMAN | |||||
Gene Name | PAK3 | |||||
Synonyms |
Beta-PAK; Oligophrenin-3; p21-activated kinase 3; PAK-3
Click to Show/Hide
|
|||||
Representative Drug(s) | PF-3758309 | Drug Info | IC50 = 99 nM | [1] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor. ACS Med Chem Lett. 2015 May 22;6(7):776-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.